JD Health International Inc. (6618.HK)

HKD 28.3

(-1.57%)

EBITDA Summary of JD Health International Inc.

  • JD Health International Inc.'s latest annual EBITDA in 2023 was 2.93 Billion CNY , up 5023.85% from previous year.
  • JD Health International Inc.'s latest quarterly EBITDA in 2023 FY was N/A , up 5023.85% from previous quarter.
  • JD Health International Inc. reported an annual EBITDA of -60.93 Million CNY in 2022, up 95.56% from previous year.
  • JD Health International Inc. reported an annual EBITDA of -1.37 Billion CNY in 2021, down -476.3% from previous year.
  • JD Health International Inc. reported a quarterly EBITDA of 987.17 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • JD Health International Inc. reported a quarterly EBITDA of N/A for 2023 FY, up 5023.85% from previous quarter.

Annual EBITDA Chart of JD Health International Inc. (2023 - 2017)

Historical Annual EBITDA of JD Health International Inc. (2023 - 2017)

Year EBITDA EBITDA Growth
2023 2.93 Billion CNY 5023.85%
2022 -60.93 Million CNY 95.56%
2021 -1.37 Billion CNY -476.3%
2020 364.5 Million CNY -16.57%
2019 436.88 Million CNY 37.8%
2018 312.64 Million CNY 22.33%
2017 259.14 Million CNY 0.0%

Peer EBITDA Comparison of JD Health International Inc.

Name EBITDA EBITDA Difference
Aidigong Maternal & Child Health Limited 68.84 Million HKD -4156.174%
UMP Healthcare Holdings Limited 161.98 Million HKD -1709.023%
Human Health Holdings Limited 104.06 Million HKD -2715.855%
EuroEyes International Eye Clinic Limited 292.1 Million HKD -903.167%
Kato (Hong Kong) Holdings Limited 133.61 Million HKD -2093.151%
Bamboos Health Care Holdings Limited 52.75 Million HKD -5454.212%
Beijing Health (Holdings) Limited -44.19 Million HKD 6730.968%
C-MER Eye Care Holdings Limited 359.88 Million HKD -714.237%
Town Health International Medical Group Limited 53.5 Million HKD -5377.077%
Medicskin Holdings Limited 6.77 Million HKD -43145.145%
Hang Chi Holdings Limited 81.58 Million HKD -3491.615%